NCT00125684View on ClinicalTrials.gov

Bioavailability and Effectiveness of Transdermally Administered Morphine

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2008

Conditions
CancerPain
Interventions
DRUG

morphine

Trial Locations (1)

T2N 4N2

Tom Baker Cancer Centre, Calgary

All Listed Sponsors
collaborator

Tom Baker Cancer Centre

OTHER

lead

Alberta Health services

OTHER

NCT00125684 - Bioavailability and Effectiveness of Transdermally Administered Morphine | Biotech Hunter | Biotech Hunter